<?xml version="1.0" encoding="UTF-8"?>
<results title="country">
 <result pre="treatment data. The highest number of papers was published by" exact="the USA" post="(nâ€‰=â€‰25, reporting 2559 treatment courses), followed by China (nâ€‰=â€‰16,"/>
 <result pre="by the USA (nâ€‰=â€‰25, reporting 2559 treatment courses), followed by" exact="China" post="(nâ€‰=â€‰16, reporting 14,680 treatment courses) and Spain (nâ€‰=â€‰16, reporting"/>
 <result pre="courses), followed by China (nâ€‰=â€‰16, reporting 14,680 treatment courses) and" exact="Spain" post="(nâ€‰=â€‰16, reporting 4103 treatment courses). Country-level data describing the"/>
 <result pre="(such as the sudden end to the EVD outbreak in" exact="Liberia" post="that prematurely halted a clinical treatment trial) [25] or"/>
 <result pre="geographic diversity and global epidemiology. In the results reported here," exact="China" post="was heavily represented and reported the majority of treatment"/>
 <result pre="of the epidemiological literature on the 2003 SARS outbreaks in" exact="Hong Kong" post="and Toronto: a time-stratified reviewPLoS Med201075e100027210.1371/journal.pmed.100027220454570 30.IoannidisJPManzoliLDe VitoCD'AddarioMVillariPPublication delay"/>
</results>
